How to Leverage Implementation Science to Achieve Equity in Nephrology Care Delivery

IF 9.4 1区 医学 Q1 UROLOGY & NEPHROLOGY
Yuvaram N.V. Reddy MBBS MPH, Laura Ellen Ashcraft PhD MSW, Mallika L. Mendu MD MBA
{"title":"How to Leverage Implementation Science to Achieve Equity in Nephrology Care Delivery","authors":"Yuvaram N.V. Reddy MBBS MPH, Laura Ellen Ashcraft PhD MSW, Mallika L. Mendu MD MBA","doi":"10.1053/j.ajkd.2025.03.029","DOIUrl":null,"url":null,"abstract":"There are several evidence-based practices within nephrology that have the potential to meaningfully improve patient outcomes and mitigate disparities. However, these practices are inconsistently implemented in routine care, contributing to low-quality care, persistent health disparities, and high healthcare costs. To address these care gaps quickly, nephrology would benefit from leveraging implementation science: a multidisciplinary field that seeks to close the gap between evidence and practice by examining the optimal approach to help individuals, groups, organizations, and communities implement evidence-based interventions in real-world settings. This Perspective is designed to provide an overview of the field of implementation science and summarize how to apply implementation science in nephrology to address health disparities. To illustrate how to leverage implementation science for health equity, we also showcase two case examples focused on 1) addressing disparities in the use of sodium/glucose cotransporter-2 inhibitors (SGLT2 inhibitors) to slow the progression of chronic kidney disease, and 2) increasing equitable access to home dialysis for people with kidney failure.","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"5 1","pages":""},"PeriodicalIF":9.4000,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Kidney Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1053/j.ajkd.2025.03.029","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

There are several evidence-based practices within nephrology that have the potential to meaningfully improve patient outcomes and mitigate disparities. However, these practices are inconsistently implemented in routine care, contributing to low-quality care, persistent health disparities, and high healthcare costs. To address these care gaps quickly, nephrology would benefit from leveraging implementation science: a multidisciplinary field that seeks to close the gap between evidence and practice by examining the optimal approach to help individuals, groups, organizations, and communities implement evidence-based interventions in real-world settings. This Perspective is designed to provide an overview of the field of implementation science and summarize how to apply implementation science in nephrology to address health disparities. To illustrate how to leverage implementation science for health equity, we also showcase two case examples focused on 1) addressing disparities in the use of sodium/glucose cotransporter-2 inhibitors (SGLT2 inhibitors) to slow the progression of chronic kidney disease, and 2) increasing equitable access to home dialysis for people with kidney failure.
如何利用实施科学实现肾病护理服务的公平性
肾脏病学中有几个基于证据的实践有可能有意义地改善患者的结果并减轻差异。然而,这些做法在常规护理中执行不一致,导致护理质量低、健康差距持续存在和医疗成本高。为了快速解决这些护理差距,肾病学将受益于利用实施科学:这是一个多学科领域,旨在通过研究最佳方法来帮助个人、团体、组织和社区在现实环境中实施基于证据的干预措施,从而缩小证据与实践之间的差距。本展望旨在提供实施科学领域的概述,并总结如何将实施科学应用于肾脏病学以解决健康差距问题。为了说明如何利用实施科学促进健康公平,我们还展示了两个案例,重点是1)解决使用钠/葡萄糖共转运蛋白-2抑制剂(SGLT2抑制剂)以减缓慢性肾脏疾病进展的差异,以及2)增加肾衰竭患者公平获得家庭透析的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American Journal of Kidney Diseases
American Journal of Kidney Diseases 医学-泌尿学与肾脏学
CiteScore
20.40
自引率
2.30%
发文量
732
审稿时长
3-8 weeks
期刊介绍: The American Journal of Kidney Diseases (AJKD), the National Kidney Foundation's official journal, is globally recognized for its leadership in clinical nephrology content. Monthly, AJKD publishes original investigations on kidney diseases, hypertension, dialysis therapies, and kidney transplantation. Rigorous peer-review, statistical scrutiny, and a structured format characterize the publication process. Each issue includes case reports unveiling new diseases and potential therapeutic strategies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信